Home > Products

Products

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC4860 Spmtrien Novel isosteric charge-deficient spermine analogue
DCC4861 spongiacidin C USP7 inhibitor from the marine sponge Stylissa massa
DCC4862 Spongosine Pivotal intercellular signal transmitter
DCC4863 Spop-in-6lc Novel SPOP inhibitor, suppressing the viability and inhibiting the colony formation of ccRCC cell lines driven by cytoplasmic SPOP
DCC4864 Spt-in-1 Novel potent serine palmitoyl transferase (SPT) inhibitor
DCC4865 Sptssb-binder-18 Novel potent and selective binder of small subunit B of the serine palmitoyltransferase complex (SPTSSB)
DCC4866 Spu-106 Novel specific PAK4 inhibitor, effectively inhibiting the invasion of SGC7901 cells without cytotoxicity, regulating the PAK4/LIMK1/cofilin and PAK4/SCG10 signaling pathways
DCC4867 Sr-01000634273-1 Novel inhibitor of the in vivo aggregation of
DCC4868 Sr10098 Novel NR4A nuclear receptor modulator
DCC4869 Sr10658 Novel NR4A nuclear receptor modulator
DCC4870 Sr142948a Selective neurotensin antagonist
DCC4871 Sr-17398 Hydrochloride Novel Unc-51-Like Kinase 1 (ULK1)
DCC4872 Sr2067 Novel partial agonist of PPARgamma
DCC4873 Sr24237 Novel NR4A nuclear receptor modulator
DCC4874 Sr-3737 Potent inhibitor of both JNK3 and p38
DCC4875 Sr-4326 Novel Inhibitor of c-Jun N-terminal Kinase 3 (JNK3)
DCC4876 Sr-43845 Novel renin inhibitor
DCC4877 Sr-58611a The first selective β3 adrenergic agonist, showing to possess a profile of antidepressant activity in rodents
DCC4878 Sr8185 Novel Selective TBK1/IKK dual inhibitor with anticancer potency
DCC4879 Srctide Peptide substrate for many protein kinases, such as Blk, BTK, cKit, EPHA1, EPHB2, EPHB3, ERBB4, FAK, Flt3, IGF-1R, ITK, Lck, MET, MUSK, Ret, Src, TIE2, TrkB, VEGF-R1 (Flt-1) and VEGF-R2 (KDR)
DCC4880 Srebp-in-dhg Novel inhibitor of sterol regulatory element-binding protein (SREBP), impairing the SREBP activity by inhibiting glucose transporters and thereby activating AMP-activated protein kinase (AMPK)
DCC4881 Sri-22138 Novel mixed μ opioid receptor (MOR) agonist and δ/κ opioid receptor (DOR/KOR) antagonist
DCC4882 Sri-29132 Highly blood-brain barrier permeant, potent, and selective for LRRK2 kinase activity, being effective in attenuating pro-inflammatory responses in macrophages and rescuing neurite retraction phenotypes in neurons.
DCC4883 Sri-31040 Potent DAT allosteric modulator, partially inhibiting DAT uptake without altering DAT-mediated reverse transport and with minimal inhibition of DAT binding
DCC4884 Sri-35241 Novel inhibitor of thrombospondin 1 activation of TGF-β, blocking TGF-β activation (pIC50 = 8.12 nM) and has a plasma half life of 1.8 h (iv)
DCC4885 Sri-36160 Novel potent inhibitor of Wn/ß-catenin signaling in cancer cells
DCC4886 Sri-37683 Novel GLUT inhibitor, preferentially inhibiting the growth of GBM cells with minimal toxicity to non-neoplastic astrocytes and neurons, also inhibiting glucose uptake and decrease the glycolytic capacity and glycolytic reserve capacity of GBM patient-deri
DCC4887 Sri-37684 Novel GLUT inhibitor, preferentially inhibiting the growth of GBM cells with minimal toxicity to non-neoplastic astrocytes and neurons, also inhibiting glucose uptake and decrease the glycolytic capacity and glycolytic reserve capacity of GBM patient-deri
DCC4888 Sri-39067 Novel MOR agonist/DOR antagonist that produced systemically active potent antinociceptive activity in tail-flick assay in mice
DCC4889 Srt3025 Novel Sirtuin1 Activator, Down-Regulating Sclerostin and Rescuing Ovariectomy-Induced Bone Loss

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X